Skip to main content
Clinical Trials/NL-OMON32078
NL-OMON32078CompletedPhase 4

Ambulation performance in chronic stroke patients using an implanted drop foot stimulator - AMPECS

niversiteit Maastricht0 sites10 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • * age ><= 18 years;
  • * first ever supratentorial stroke with persistent neurological deficit
  • * post-stroke time between 6 and 24 months;
  • * Diagnosis and stroke severity
  • * BARTHEL INDEX * 15
  • * clinically diagnosed central paresis of the leg;
  • * drop foot, i.e. inability to achieve a normal heel strike during walking
  • * balance and gait-related criteria: subject is an outdoor walker:
  • * Berg Balance score 48/56;
  • * Rivermead mobility index 11/15.
  • * strength MRC grade * 3 at entry into the study
  • * no injury to peroneal nerves and sciatic nerve
  • * ( EMG to exclude peripheral nerve lesion,
  • * trial stimulation to evaluate dorsiflexion and eversion of the foot)

Exclusion Criteria

  • * pacemaker
  • * any medical condition that would exclude the use of a surgical procedure or anaesthetic
  • * pregnancy
  • * inability to read or understand Dutch or receptive aphasia?
  • * no informed consent

Investigators

Similar Trials